Where does Progenics Pharmaceuticals, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Progenics Pharmaceuticals, Inc. ranks #14,219 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Progenics Pharmaceuticals, Inc. hold?

Progenics Pharmaceuticals, Inc. holds 21 US utility patents granted between 2015 and 2025, spanning 13 technology areas.

What is Progenics Pharmaceuticals, Inc.'s Innovation Score?

Progenics Pharmaceuticals, Inc. has an Innovation Score of 47.8 out of 100 (top 18% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Progenics Pharmaceuticals, Inc.'s patent grant rate increasing or decreasing?

Progenics Pharmaceuticals, Inc.'s recent grant velocity is +43% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Progenics Pharmaceuticals, Inc.'s patents?

Progenics Pharmaceuticals, Inc.'s patents average 27.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Progenics Pharmaceuticals, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Progenics Pharmaceuticals, Inc.

Q: What technology areas does Progenics Pharmaceuticals, Inc. focus on?

Progenics Pharmaceuticals, Inc.'s top technology area is G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data) with 14 patents, ranking #352 of 3,149 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

USPTO PatentsView assignee record - 21 granted patents across 13 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Progenics ranks #14,219 of 49,997 tracked US assignees by granted-patent volume, with 21 patents across 13 technology areas.

#14,219
of 49,997 US assignees by volume: Top 18%
by Innovation Score (47.8/100): 27.9
avg claims per patent: +43%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14219 · US Corporation #14,219 · 21 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 21 grants
MID-PACK #14,219/49,997
PHOTO-FINISH PostProcess
CPC-FOCUS G16H · 13 areas
INNOV-PAR 47.8/100
CLAIMS-DENSE 27.9 claims/avg
TYPE-USCORP US Corporation
VEL-UP +43% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: PostProcess Technologies, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Progenics’s 47.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.7 pts (22%) Velocity 9.3 pts (19%) Breadth 12.7 pts (27%) Claim depth 15.0 pts (31%)

Qualcomm Incorporated · highest

85
Progenics Pharmaceut… · this assignee

48
3D Lighting… · lowest

7

What this shows Progenics's Innovation Score is 47.8/100 (top 18% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Progenics?

Each dot is one of Progenics’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Progenics’s own 27.9 claims/patent is ABOVE the 14.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Progenics vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Progenics's grants concentrate

Progenics Pharmaceuticals, Inc. is a focused PatentsView assignee: 13 CPC subclasses with 66.7% of grants classified under G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data). Peak complete grant year is 2024 (5 grants) versus a trough of 1 in 2018. By volume, Progenics sits between PostProcess Technologies, Inc. and Quad/Graphics, Inc..

Progenics's three-year grant acceleration

Progenics Pharmaceuticals, Inc. shows 7 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Postprocess

21
Powerblock Holdin…

21
Premier Manufactu…

21
Prevayl Innovatio…

21
Q Bio

21
Qianhai Junda (Sh…

21
Qingdao Sentury T…

21
Quad/Graphics

21
Progenics Pharmac… ◀

21

What this shows Progenics holds 21 patents at rank #14,218, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Progenics

By rank, the assignees closest to #14,218 in granted patent volume.

Leaders in G16H (Healthcare Informatics)

Other assignees with the most granted patents in Progenics's primary technology class.

Progenics's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 18% higher than 82% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Progenics Pharmaceuticals, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	9.5%
2017	2	9.5%
2018	1	4.8%
2019	2	9.5%
2020	2	9.5%
2021	1	4.8%
2022	1	4.8%
2023	1	4.8%
2024	5	23.8%
2025partial year	4	19.0%

Which technologies does Progenics Pharmaceuticals, Inc. patent most?

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 14

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 9

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 8

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 6

G06T - Image Data Processing OR Generation, IN General 6

G06F - Electric Digital Data Processing 3

G06V - Image OR Video Recognition OR Understanding 3

A61B - DIAGNOSIS; SURGERY; Identification 3

C07D - Heterocyclic Compounds 3

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 2

G06N - Computing Arrangements Based ON Specific Computational Models 2

Y10T - Technical Subjects Covered BY Former US Classification 1

C07K - Peptides 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Progenics Pharmaceuticals, Inc.'s patent record in context - here's where to go next.

Progenics Pharmaceuticals, Inc.'s lead technology class is G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data), 66.7% of its portfolio - see every assignee active in that class. Explore G16H
Ranked #14,219 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Progenics Pharmaceuticals, Inc. against PostProcess Technologies, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 47.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.